Oruka Therapeutics, Inc. (ORKA)
64.59
+0.52
(+0.81%)
USD |
NASDAQ |
May 08, 16:00
64.57
-0.02
(-0.03%)
After-Hours: 20:00
Oruka Therapeutics EPS Diluted (Quarterly) : -0.5436 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Liminatus Pharma, Inc. | -0.3018 |
| MapLight Therapeutics, Inc. | -1.807 |
| Kailera Therapeutics, Inc. | -- |
| Veracyte, Inc. | 0.353 |
| Insight Molecular Diagnostics, Inc. | -0.7159 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -29.58M |
| Total Expenses (Quarterly) | 29.58M |
| Enterprise Value | 2.868B |
| Earnings Yield | -3.59% |
| Normalized Earnings Yield | -3.589 |